Ribozyme-mediated inactivation of mutant K-ras oncogene in a colon cancer cell line

British Journal of Cancer

Volumn 83, Issue 6, 2000, Pages 833-839

  Tokunaga, T ^a,b   Tsuchida, T ^a   Kijima, H ^a   Okamoto, K ^c   Oshika, Y ^a   Sawa, N ^c   Ohnishi, Y ^c   Yamazaki, H ^a   Miura, S ^b   Ueyama, Y ^a   Nakamura, M ^a  

^a TOKAI UNIVERSITY   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^c CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

Author keywords

Angiogenic factor; Colon cancer; K ras oncogene; Ribozyme

Indexed keywords

ANGIOGENIC FACTOR; BETA ACTIN; DNA FRAGMENT; MESSENGER RNA; RIBOZYME; THROMBOSPONDIN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CHROMATIN CONDENSATION; COLON CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE INACTIVATION; GENE SEQUENCE; GENETIC TRANSFECTION; GROWTH RATE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; ONCOGENE K RAS; PRIORITY JOURNAL; XENOTRANSPLANTATION;

EID: 0033818148     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1363     Document Type: Article

References (37)

1. Kirsten ras mutations in patients with colorectal cancer: The multicenter 'RASCAL' study
2. Oligonucleotide modulation of multidrug resistance
3. In vitro splicing of the ribosomal RNA precursor of tetrahymena: Involvement of a guanosine nucleotide in the excision of the intervening sequence
4. Oncogenic Ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cells
5. Genetic alterations in the adenoma carcinoma sequence
6. Neoplastic reversion accomplished by high efficiency adenoviral-mediated delivery of an anti-ras ribozyme
7. Brain-specific angiogenesis inhibitor 1 expression is inversely correlated with vascularity and distant metastasis of colorectal cancer
8. Both v-Ha-Ras and v-Raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells
9. Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1
10. Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression
11. Therapeutic applications of ribozymes
12. Ribozymes as a novel approach for the treatment of human pancreatic carcinoma
13. Screening for colorectal cancer
14. Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor
15. Regulation of myeloid cell growth by distinct effectors of Ras
16. Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression
17. Tissue-specific expression of an anti-ras ribozyme inhibits proliferation of human malignant melanoma cells
18. Impact of oncogenes in tumor angiogenesis: Mutant K-ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells
19. Thrombospondin2 gene expression is correlated with decreased vascularity in non-small cell lung cancer
20. Expression of cell-associated isoform of vascular endothelial growth factor 189 and its prognostic relevance in non-small cell lung cancer
21. Mutant ras oncogenes upregulate VEGF/VPF expression: Implications for induction and inhibition of tumor angiogenesis
22. Genetic heterogeneity in sporadic colorectal adenomas
23. Ribozyme-mediated cleavage of c-fos mRNA reduces gene expression of DNA synthesis enzymes and metallothionein
24. Oligonucleotide-mediated modulation of mammalian gene expression
25. Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by yon Hippel-Lindau tumor suppressor protein
26. Altered growth of human colon cancer cell lines disrupted at activated Ki-ras
27. Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer
28. Alterations in tumour suppressor gene p53 correlate with inhibition of thrombospondin-1 gene expression in colon cancer cells
29. Thrombospondin-2 expression is correlated with inhibition of angiogenesis and metastasis of colon cancer
30. Expression of vascular endothelial growth factor isoform is closely correlated with tumor stage and vascularisation in renal cell carcinoma
31. Hammerhead ribozyme specifically inhibits mutant K-ras mRNA of human pancreatic cancer cells
32. Expression of the thrombospondin 1 receptor CD36 is correlated with decreased stromal vascularisation in colon cancer
33. Adenovirus-mediated anti-K-ras ribozyme induces apoptosis and growth suppression of human pancreatic carcinoma
34. Sequential development of an angiogenic phenotype by human fibroblasts progressing to tumorigenity
35. Activation of the K-ras oncogene in colorectal neoplasms is associated with decreased apoptosis
36. Inhibition of tumor growth by ribozyme-mediated suppression of aberrant epidermal growth factor receptor gene expression
37. Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung, and breast carcinoma cell lines